1. Weight reduction in boys with muscular dystrophy;Edwards, R.H.T.; Round, J.M.; Jackson, M.J.; Griffiths, R.D.; Lilburn, M.F.;Dev Med Child Neurol,1984
2. Creatinine excretion during growth;Graystone, J.G.,1968
3. Clinical longitudinal standards for height, weight, height velocity and weight velocity and stages of puberty;Tanner, J.M.; Whitehouse, R.H.;Arch Dis Child,1976
4. Total body potassium and water, and exchangeable sodium, in muscular dystrophy;Edmonds, C.J.; Smith, T.; Griffiths, R.D.; Mackenzie, J.; Edwards, R.H.T.;Clin Sci,1985
5. Determination of the 'power' of therapeutic trials based on the natural history. Muscle Nerve 1983; 6: 91-103. Routine screening was instituted in 1978 after reports that it reduced the need for exchange transfusions in ABO incompatible infants by allowing early detection.2 Data were collected on 110 ABO incompatible deliveries (94 mother group 0/infant group A (0-A), 16 mother group 0/infant group B (0-B)) in which the cord blood elution test was positive. The elution test was graded as weakly positive or strongly positive. A control group